3
Farahmand, S. J. Iran. Chem. Soc. 2013, 10, 577–581; (c) Wang,
H. J.; Zhang, X. N.; Zhang, Z. H. Monatsh. Chem. 2010, 141,
425–430; (d) Soheilizad, M.; Adib, M.; Sajjadifar, S. Monatsh.
Chem. 2014, 145, 1353–1356; (e) Abedini, M.; Shirini, F.; Omran,
J. M.–A. J. Mol. Liq. 2015, 212, 405–412; (f) Tayebee, R.; Jomei,
M. Maleki, B.; Razi, M. K.; Veisi, H.; Bakherad, M. J. Mol. Liq.
2015, 206, 119–128.
62
2i
a Reagents and conditions: benzaldehyde (1.1 mmol), 1,3-cyclohexadione (1.2
mmol), phthalhydrazide (1 mmol), acetic acid (5 mL), trifluoroacetic acid (2
mL) then phenylhydrazine (1.7 eq.), trifluoroacetic acid (2 mL), reflux.
b Isolated yield from phthalhydrazide.
14. Representative procedure for the synthesis of 16-phenyl-1,16-
dihydrophthalazino[2',3':1,2]pyrazolo[4,3-a]carbazole-9,14-dione
2a: To a mixture of acetic acid (5 mL) and trifluoroacetic acid (2
mL) in a 50 mL round-bottomed flask, benzaldehyde (1.1 mmol),
1,3-cyclohexadione (1.2 mmol) and phthalhydrazide (1 mmol)
were added. The resulting mixture was magnetically stirred at
reflux for 4 h. After completion (TLC), the reaction mixture was
cooled and phenylhydrazine (1.7 eq.) and trifluoroacetic acid (2
mL) were added. The reaction mixture was heated at reflux for 24
h. Upon completion, the solvents were removed under reduced
pressure and the product was isolated by chromatography.
Compounds 2b-c, 2e, 2j-i were obtained analogously to 2a.
Compounds 2d and 2f precipitated during solvent evaporation and
were isolated by filtration then washed with AcOH.
c
Products precipitated during solvent evaporation and were isolated by
filtration then washed with AcOH.
In conclusion, we have reported an efficient and convenient
protocol for the one-potsynthesis of polycyclic carbazole
derivatives from phthalhydrazide, benzaldehyde, cyclohexane-
1,3-dione and phenylhydrazine using a sequential MCR/Fisher
indolization strategy. This method is quite general and works
with a broad range of substrates.
15. Crystal structure analysis for 2a: C27H17N3O2, Mr = 415.13 g/mol,
Orthorhombic, space group
P
212121, a=10.5723(6) Å;
Acknowledgments
b=10.7384(6)Å ; c=21.6020(11)Å; α=β=γ=90°, Z=4, V=
2452.5(2)Å3, Z=4, c=1.323, F(000)=1024, crystal size:
0.14×0.11×0.09 mm. Crystallographic data (excluding structure
factors) for compound 2a have been deposited with the Cambridge
Crystallographic Data Centre as supplementary publication
number CCDC 978520. This data can be obtained free of charge
from The Cambridge Crystallographic Data Centre via
We thank MESRS (Ministère de l’Enseignement Supérieur et
de la Recherche Scientifique) Algeria, for Financial support.
References and notes
1.
(a) Knölker, H. –J.; Reddy, K. R. Chem. Rev. 2002, 102, 4303–
4427; (b) Knölker, H. –J. Top. Curr. Chem. 2005, 244, 115–148.
(a) Issa, S.; Walchshofer, N.; Kassab, I.; Termoss, H.; Chamat, S.;
Geahchan, A.; Bouaziz, Z. Eur. J. Med. Chem. 2010, 45, 2567–
2577; (b) Rongved, P.; Kirsch, G.; Bouaziz, Z.; Jose, J.; Le
Borgne, M. Eur. J. Med. Chem. 2013, 69, 465–479; (c) Bouaziz,
Z.; Issa, S.; Gentili, J.; Gratz, A.; Bollacke, A.; Kassack, M.; Jose,
J.; Herfindal, L.; Gausdal, G.; Døskeland, S. O.; Mullié, C.;
Sonnet, P.; Desgrouas, C.; Taudon, N.; Valdameri, G.; Di Pietro,
A.; Baitiche, M.; Le Borgne, M. J. Enzyme Inhib. Med. Chem.
2015, 30, 180–188.
2.
16. (a) Lamera, E.; Benzerka, S.; Bouraiou, A.; Bouacida, S.;
Merazig, H.; Chibani, A.; Le Borgne, M.; Bouaziz, Z. Acta Cryst.
2015, E71, o1036–o1037 ; (b) Bouraiou, A.; Bouacida, S.;
Merazig, H.; Chibani, A.; Bouaziz, Z. Acta Cryst. 2015, E71,
o604–o605.
Highlights
3.
4.
Tucker, J.; Sviridov, S.; Brodsky, L.; Burkhart, C.; Purmal, A.;
Gurova, K.; Gudkov, A. Eur. Patent 2,356,093, 2009.
-
-
-
A method for the synthesis of novel
polycyclic carbazoles is described.
sequential MCR/Fisher indolization
(a) Goodwin, S.; Smith, A. F.; Horning, E. C. J. Am. Chem. Soc.
1959, 81, 1903–1908; (b) Gribble, G. W. In Alkaloids; Brossi, A.
Ed.; Academic Press: New York, 1990; Vol. 39, p 239–352; (c)
Kansal, V. K.; Potier, P. Tetrahedron 1986, 42, 2389–2408; (d)
Ishikura, M.; Hino, A.; Yaginuma, T.; Agata, I.; Katagiri, N.
Tetrahedron 2000, 56, 193–207; (e) Diaz, M. T.; Cobas, A.;
Guitian, E.; Castedo, L. Synlett 1998, 157–158; (f) Ergun, Y.;
Patir, S.; Okay, G. J. Heterocycl. Chem. 1998, 35, 1445–1447.
Giraud, F.; Akué–Gédu, R.; Nauton, L.; Candelon, N.; Debiton,
E.; Théry, V.; Anizon, F.; Pascale Moreau, P. Eur. J. Med. Chem.
2012, 56, 225–236.
A
strategy was described.
Phthalazine was used as a starting material
for the construction of polycyclic
compounds.
5.
6.
Lee, H. J.; Schaefer, G.; Heffron, T. P.; Shao, L.; Ye, X.;
Sideris, S.;
Malek, S.;
Chan, E.;
Merchant, M.;
La, H.;
Ubhayakar, S.; Yauch, R. L.; Pirazzoli, V.; Politi K.; Settleman, J.
Cancer Discov. 2013, 3, 168–181.
7.
8.
9.
Xue, D. Q.; Zhang, X. Y.; Wang, C. J.; Ma, L. Y.; Zhu, N.; He, P.;
Shao, K. P.; Chen, P. J.; Gu, Y. F.; Zhang, X. S.; Wang, C. F.; Ji,
C. H.; Zhang, Q. R.; Liu, H. M. Eur. J. Med. Chem. 2014,
85, 235–244.
(a) Zhang, Q. R.; Xue, D. Q.; He, P.; Shao, K. P.; Chen, P. J.; Gu,
Y. F.; Ren, J. L.; Shan, L. H.; Liu, H. M. Bioorg. Med. Chem. Lett.
2014, 24, 1236–1238; (b) Khalil, A. M.; Berghot, M. A.; Gouda,
M. A. Eur. J. Med. Chem. 2009, 44, 4448–4454.
(a) Liu, D. C.; Gong, G. H.; Wei, C. X.; Jin, X. J.; Quan, Z. S.
Bioorg. Med. Chem. Lett. 2016, 26, 1576–1579; (b) Sun, X. Y.;
Hu, C. Deng, X. Q.; Wei, C. X.; Sun, Z. G.; Quan, Z. S. Eur. J.
Med. Chem. 2010, 45, 4807–4812.
10. Grasso, S.; De Sarro, G.; De Sarro, A.; Micale, N.; Zappalà, M.;
Puja, G.; Baraldi, M.; De Micheli, C. J. Med. Chem. 2000, 43,
2851–2859.
11. Wilson, C. L.; Apatu, J. O. J. Heterocyclic Chem. 1989, 26, 571–
576.
12. Sangani, C. B.; Makwana, J. A.; Duan, Y. T.; Thumar, N. J.;
Zhao, M. Y.; Patel, Y. S.; Zhu, H. L. Res. Chem. Intermed. 2016,
42, 2101–2117.
13. (a) Davarpanah, J.; Rezaee, P.; Elahi, S. Res. Chem. Intermed.
2015, 41, 9903–9915; (b) Zolfigol, M. A.; Mokhlesi, M.;